VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VYCOR MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.24M
- P/E (TTM)
- –
- Dividend yield
- –
VYCOR MEDICAL INC revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vycor Medical Inc [Member] | $1.74M | $1.82M | $1.80M | $1.83M | $1.71M | $1.62M | $1.52M | – | – | – | – | – | 96.1% | +1.6% |
| NovaVision Inc [Member] | $70.05K | $67.57K | $67.33K | $72.24K | $68.56K | $73.03K | $73.58K | – | – | – | – | – | 3.9% | +2.2% |
| Vycor Medical [Member] | – | – | – | – | – | – | $1.52M | $1.37M | $1.28M | $1.36M | $1.38M | $1.34M | – | – |
| NovaVision [Member] | – | – | – | – | – | – | $73.58K | $72.86K | $75.88K | $76.29K | $82.01K | $80.73K | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vycor Medical Inc [Member] | $469.45K | $567.42K | $493.79K | $547.61K | $452.90K | $358.66K | $353.05K | – | – | – | – | – | +3.7% |
| NovaVision Inc [Member] | -$196.23K | -$194.70K | -$183.88K | -$180.09K | -$178.61K | -$173.29K | -$177.92K | – | – | – | – | – | +9.9% |
| Corporate Segment [Member] | -$225.00K | -$280.20K | -$276.01K | -$277.75K | -$251.74K | -$197.78K | -$184.28K | -$160.09K | -$159.47K | -$151.95K | -$151.85K | -$152.99K | -10.6% |
| Vycor Medical [Member] | – | – | – | – | – | – | $353.05K | $240.55K | $248.23K | $333.88K | $383.85K | $367.48K | – |
| NovaVision [Member] | – | – | – | – | – | – | -$177.92K | -$173.00K | -$171.65K | -$72.63K | -$191.81K | -$89.59K | – |
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.80M | $1.88M | $1.86M | $1.90M | $1.78M | $1.69M | $1.59M | $1.44M | $1.36M | $1.43M | $1.45M | $1.42M | 99.5% | +1.3% |
| Europe [Member] | $8.44K | $7.35K | $4.91K | $3.32K | $2.85K | $3.04K | $3.68K | $4.36K | $4.65K | $5.37K | $6.71K | $6.32K | 0.5% | +195.8% |
From the segment and revenue-disaggregation notes of Vycor Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.